Renal Cancer - Results from #820

Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022. July 19, 2023

Impact of BMI on the Survival of Renal Cell Carcinoma Patients Treated with Targeted Therapy: A Systematic Review and Meta-Analysis. July 19, 2023

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808. July 18, 2023

Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma. July 18, 2023

Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial. July 17, 2023

The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. July 17, 2023

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma. July 17, 2023

Diagnosis, treatment, and survival from kidney cancer: real-world NHS England data between 2013-2019. July 14, 2023

Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma. July 14, 2023

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely. July 14, 2023

The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs. July 13, 2023

Establishment and validation of a prognostic nomogram for patients with renal cell carcinoma based on SEER and TCGA database. July 13, 2023

Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. July 13, 2023

Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features. July 12, 2023

Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma. July 12, 2023

Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy. July 11, 2023

Genomic profiles of renal cell carcinoma in a small Chinese cohort. July 11, 2023

Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10). July 10, 2023

Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery. July 10, 2023

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial. July 10, 2023

Page 42 of 455